Monsanto Rating Increased to Neutral at Monness, Crespi, Hardt (MON)

By admin | 6 years ago

Monsanto (NYSE: MON) was upgraded by research analysts at Monness, Crespi, Hardt to a “neutral” rating in a report released on Tuesday.

Shares of Monsanto opened at 72.08 on Tuesday. Monsanto has a 52 week low of $58.89 and a 52 week high of $83.95. The company has a market cap of $38.450 billion and a P/E ratio of 20.37.

Monsanto last announced its earnings results on Wednesday, April 4th. The company reported $2.28 EPS for the quarter, beating the Thomson Reuters consensus estimate of $2.11 by $0.17. The company’s quarterly revenue was up 14.9% on a year-over-year basis. On average, analysts predict that Monsanto will post $-0.23 earnings per share next quarter.

MON has been the subject of a number of other recent research reports. Analysts at Goldman Sachs (NYSE: GS) downgraded shares of Monsanto to a “buy” rating in a research note to investors on Monday, April 9th. They now have a $90.00 price target on the stock. Separately, analysts at Zacks downgraded shares of Monsanto from an “outperform” rating to a “neutral” rating in a research note to investors on Thursday, April 5th. They now have a $85.00 price target on the stock. Finally, analysts at Piper Jaffray (NYSE: PJC) raised their price target on shares of Monsanto from $95.00 to $97.00 in a research note to investors on Thursday, April 5th.

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers.

About the author